API-2-Induced Cell Migration Is Overcome by Small Molecular Approaches Inhibiting β-Catenin |
| |
Authors: | Yonghyo Kim Myoung-Hee Kang Yong-Hee Cho |
| |
Affiliation: | 1.Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea;2.Department of Plastic and Reconstructive Surgery, Seoul National University Boramae Medical Center, Seoul 07061, Republic of Korea |
| |
Abstract: | Frequent mutation of APC (90%) in advanced colorectal cancer (CRC) results in the simultaneous activation of Wnt/β-catenin and AKT signaling pathways, and the current therapeutic limitations of the AKT inhibitors for treating CRC patients are nuclear β-catenin-induced EMT and bypassing apoptosis. In this study, we discover that the combinatorial treatment of an AKT inhibitor and KY1022, a β-catenin destabilizer, effectively overcomes the current limitations of API-2, an AKT inhibitor, by reducing nuclear β-catenin. Taken together, we demonstrate that the simultaneous suppression of Wnt/β-catenin with the AKT signaling pathways is an ideal strategy for suppressing the AKT-inhibitor-mediated metastasis and for maximizing the therapeutic effects of AKT inhibitors. |
| |
Keywords: | colorectal cancer, cell migration, EMT, resistance to AKT inhibitor, Wnt/β -catenin pathway, PI3K-AKT pathway, FOXO3a |
|
|